389.85
-1.7(-0.43%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
6659
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Ameya Ashok Chandavarkar | Chief Executive Officer of International Business & Executive Director | 24.1M | 1978 |
| Ashok Anand Chandavarkar | Whole Time Director | 20.66M | N/A |
| Nandan Mohan Chandavarkar | Joint MD & Executive Director | 37.26M | N/A |
| Mohan Anand Chandavarkar | BR Head, MD & Director | 44.83M | N/A |
| Mayank Tikkha | Senior Vice President Business Development | 0 | N/A |
| Sanjay Jain | Vice President of Corporate Finance | 0 | N/A |
| Shashank Vyapari | Vice President of Technical & Operations | 0 | N/A |
| Vishal Shah | Chief Financial Officer | 0 | N/A |
| Zafrullah Khan | Senior Vice President Human Resources | 0 | 1968 |
| Varsharani Rajaram Katre | Legal Head, Compliance Officer & Company Secretary | 0 | N/A |
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.